# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-013242
Filing Date
2026-03-27
Accepted
2026-03-27 17:00:36
Documents
90
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | form10-k.htm iXBRL | 10-K | 4218503
2 | EX-21.1 | ex21-1.htm | EX-21.1 | 5635
3 | EX-23.1 | ex23-1.htm | EX-23.1 | 3813
4 | EX-23.2 | ex23-2.htm | EX-23.2 | 3816
5 | EX-31.1 | ex31-1.htm | EX-31.1 | 18310
6 | EX-31.2 | ex31-2.htm | EX-31.2 | 18422
7 | EX-32.1 | ex32-1.htm | EX-32.1 | 7841
8 | EX-32.2 | ex32-2.htm | EX-32.2 | 7747
| Complete submission text file | 0001493152-26-013242.txt |  | 15712796

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | cldi-20251231.xsd | EX-101.SCH | 96020
10 | XBRL CALCULATION FILE | cldi-20251231_cal.xml | EX-101.CAL | 114456
11 | XBRL DEFINITION FILE | cldi-20251231_def.xml | EX-101.DEF | 373468
12 | XBRL LABEL FILE | cldi-20251231_lab.xml | EX-101.LAB | 802558
13 | XBRL PRESENTATION FILE | cldi-20251231_pre.xml | EX-101.PRE | 578621
93 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 2878469

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40789 | Film No.: 26808340
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)